Article Information
History
- May 19, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Luke A. Perera#,1,5,
- Andrew T. Hattersley#,2,
- Heather P. Harding#,1,
- Matthew N. Wakeling#,2,
- Sarah E. Flanagan2,
- Ibrahim Moshina3,
- Jamal Raza3,
- Alice Gardham4,
- David Ron∞,§,1 and
- Elisa De Franco∞,§,2
- 1Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom
- 2Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, United Kingdom
- 3National Institute of Child Health, Department of Endocrine and Diabetes, Karachi, Pakistan
- 4North West Thames Regional Genetics Service, Harrow, United Kingdom
- 5The Francis Crick Institute; 1 Midland Road; London; NW1 1AT
- ↵§Corresponding authors Elisa De Franco: e.de-franco{at}exeter.ac.uk David Ron: dr360{at}medschl.cam.ac.uk
↵#,∞ Equal contribution
Posted May 19, 2022.
A homozygous p.(Arg371Ser) mutation in FICD de-regulates AMPylation of the human endoplasmic reticulum chaperone BiP causing infancy-onset diabetes and severe neurodevelopmental delay
